Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
insulin glargine (toujeo) (1 trial)
tranexamic acid (cyklokapron) (1 trial)
cisplatin (platinol) (1 trial)
arhalofenate (1 trial)
autologous mesenchymal stem cells (1 trial)
pioglitazone (actos) (1 trial)
sitagliptin (januvia) (1 trial)
branched chain amino acids (1 trial)
lactulose (cephulac) (1 trial)
sulindac (clinoril) (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Foot (Phase 4)
Foot Ulcer (Phase 4)
Ischemia (Phase 2)
Ulcer (Phase 4)
Trials (7 total)
Trial APIs (10 total)